- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06842446
Algoritmo sistemático de aprendizaje automático para detección de trombosis rápida (DVT-SMART)
Evaluación de una nueva estrategia de diagnóstico para la Sospecha de DVT que consiste en Point of Care D-Dimer, modelo de predicción basado en IA y ultrasonido de compresión
The goal of this clinical trial is to compare the use of a machine learning-based algorithm and point-of-care D-dimer to laboratory D-dimer and compression ultrasound to exclude deep vein thrombosis in the under extremities in patients referred to a medical department suspected of having deep vein thrombosis. The main aim is to answer are if a machine learning algorithm and point of care D-dimer can exclude deep vein thrombosis in more patients than clinical assessment and D-dimer alone.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
All participants will follow the usual diagnostic algorithm used for patients with suspected DVT referred to Ostfold Hospital (all patients are examined by a physician, D-dimer is analyzed in all patients, ultrasound is performed by a radiologist in patients with positive D-dimer). In addition to usual care, POC D-dimer, POC ultrasound (performed by ED physicians), blood sampling for biobanking, and photographies of the under extremities will be performed. The machine learning model will be tested to see if the prediction is correct. In participants where ultrasound is performed, it will also be assessed whether the machine learning algorithm could have excluded the participant without the use of ultrasound. None of the additional procedures will have any impact on the patient diagnostics or treatment.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Waleed Ghanima, Professor
- Número de teléfono: 0047 69860000
- Correo electrónico: waleed.ghanima@so-hf.no
Copia de seguridad de contactos de estudio
- Nombre: Hans Joakim Myklebust-Hansen, Medical Doctor
- Número de teléfono: 0047 97501765
- Correo electrónico: hans.joakim.hansen@so-hf.no
Ubicaciones de estudio
-
-
-
Sarpsborg, Noruega, 1714
- Reclutamiento
- Østfold Hospital Trust
-
Contacto:
- Hans J Myklebust-Hansen, M.D.
- Número de teléfono: 004797501765
- Correo electrónico: hansjoakim_mh@outlook.com
-
Sub-Investigador:
- Hans J Myklebust-Hansen, M.D.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients referred to the ED due to suspicion of DVT
- Age ≥ 18 years
- Able to give informed consent
Exclusion Criteria:
- Ongoing use of anticoagulation for more than 72 hours
- Previous participation in the study
- Life expectancy of less than three months.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: All participants
All participants will be treated the same way. |
POC D-dimer will be compared to laboratory D-dimer in hospital setting and used in a machine learning model Point of care (POC) ultrasound performed by ED physicians compared to ultrasound performed by radiologist. POC ultrasound 3 point examination performed by ED physician will be compared with POC ultrasound full leg examination performed by ED physician. The DSS will be compared to the usual strategy. It will also be estimated how many participants where DVT could have been excluded without ultrasound.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Safety of the new strategy (POC D-dimer, ML-based prediction model, POC CUS by emergency physician)
Periodo de tiempo: From enrollment to the end of the primary assessment period (90 days)
|
Evaluate the safety of a new strategy consisting of POC D-dimer and an ML-based prediction model followed by CUS performed by emergency physicians by comparing the new strategy's safety with our standard care by measuring the proportion of patients in whom DVT is excluded according to the new strategy but was diagnosed with DVT by standard care or in whom DVT is diagnosed within the 90-day follow up. |
From enrollment to the end of the primary assessment period (90 days)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Evaluate the efficiency of the new strategy
Periodo de tiempo: From enrollment to the end of the primary assessment period (90 days)
|
The proportion of patients in whom DVT can be ruled out by the ML-based prediction model with POC D-dimer compared to the efficiency of Wells score and laboratory D-dimer |
From enrollment to the end of the primary assessment period (90 days)
|
|
Validate the safety and efficiency of the ML-based prediction model
Periodo de tiempo: From enrollment to the end of the primary assessment period (90 days)
|
Safety will be determined by the proportion of patients in whom DVT is excluded by the ML-model but diagnosed by standard care. Efficiency will be determined by the proportion of patients in whom DVT can be excluded by the ML-based model |
From enrollment to the end of the primary assessment period (90 days)
|
|
Evaluate concordance between CUS performed by emergency physicians and radiologists.
Periodo de tiempo: From time of enrollment until time of ultrasound examination performed by radiologist, assessed up to 48 hours.
|
Determine the proportion of false negative and false positive diagnosis of DVT in emergency physician-performed ultrasound compared with ultrasound performed by radiologists. |
From time of enrollment until time of ultrasound examination performed by radiologist, assessed up to 48 hours.
|
|
Evaluate concordance between POC D-dimers in an ED setting and laboratory D-dimers.
Periodo de tiempo: From enrollment to the completion of D-dimer analysis, assessed up to 24 hours.
|
Compare the two POC D-dimers with the STA-Liatest D-dimer and Siemens INNOVANCE by direct comparison of the true/false positive/negative results. |
From enrollment to the completion of D-dimer analysis, assessed up to 24 hours.
|
|
Evaluate the hypothetical time to be completed for the novel strategy compared to the standard strategy.
Periodo de tiempo: From time of enrollment until time of discharge from the emergency department either discharged from the hospital or hospitalized, assessed up to 24 hours.
|
Estimating the total management time defined as time from ED registration to ED discharge in patients evaluated according to the new strategy compared to standard care. |
From time of enrollment until time of discharge from the emergency department either discharged from the hospital or hospitalized, assessed up to 24 hours.
|
|
Evaluate the safety of a limited ultrasound protocol (two-point and proximal) compared to full-leg CUS performed by emergency physicians and radiologists
Periodo de tiempo: 90 days after enrollment.
|
Estimating the proportion of patients in whom DVT was ruled out by the limited ultrasound protocol but was diagnosed with DVT by the whole-leg ultrasound. |
90 days after enrollment.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 682139
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
The plan to share IPD with other researchers are not yet decided because it has not yet been discussed.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .